Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...
Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...
Recursion Pharmaceuticals, Inc (($RXRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Recursion Pharmaceuticals, ...
Yahoo Sports TVyahoosports.tv is here! Watch live shows and highlights 24/7. Yahoo Sports DailyJason Fitz & Caroline Fenton bring you the top sports news to start your day. Yahoo Fantasy ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback